Pagari Life Science

Funding and NIH signals

• SEC Form D raise Raised $97K (Form D filed May 12, 2026). SEC Form D 0001993125-26-000001 (May 12, 2026)
  Evidence (1 event)

  • May 12, 2026 · SEC Form D 0001993125-26-000001
    Name of Issuer: Pagari Life Science Corp.; CIK: 1993125; Address: Bethalta, IL; Submission type: D; Filing date: 2026-05-12; Industry Group: Pharmaceuticals; Date of First Sale: 2026-04-28; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 300000; Total Amount Sold: 97494; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals